IFNG and neoplasm: The exclusion of CD8+ T cells from the tumor prevents the cell-to-cell contact necessary for TEff cell release of cytolytic effector molecules, including IFN-γ and granzyme B. This immune-specific cell interaction targets tumor and virally infected cells, limiting damage to normal tissue in contrast with the nonspecific killing of rapidly growing cells that occurs with conventional therapies (57–60).